AI governance heats up while cure trials keep expanding
LISTEN
Direct audio file (MP3)Global active cure-related trials now total 21,249, while new wire signals in the last 24 hours reached 17 and only 1 new cure research item appeared. The most important signal is that AI policy and governance narratives are accelerating: EmTech Future 2026 spotlights AI’s cross-field expansion into biology and manufacturing, while parallel efforts—including Trump’s “Super Intelligence Force”—signal a push to govern AI at the interface as risk discussions intensify. At the same time, the wire flags a worsening safety externality: the Internet Watch Foundation reports AI-assisted imagery for child sexual abuse is already 40% above last year and that illegal cases have exceeded all of 2025. Despite the noise, restrained hope comes from the sheer throughput of cure trials continuing to scale even as the capital/AI phase transition advances. The window is still open.
EmTech Future 2026 spotlights AI’s cross-field expansion beyond software, with AI beginning to reshape biology and manufacturing via intersections.
Governance decisions and platform incentives will determine whether AI’s acceleration helps or harms—humanity gains if safety and alignment keep pace, and loses if risks outstrip control.
Watch the next 24–72 hours for whether the new “Super Intelligence Force” oversight and AI safety rhetoric translate into meaningful interface control, not just messaging.